2008
DOI: 10.1128/jvi.00662-08
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Mutated Cyclization Sequences That Permit Efficient Replication of West Nile Virus Genomes: Use in Safer Propagation of a Novel Vaccine Candidate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
32
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(35 citation statements)
references
References 45 publications
2
32
0
Order By: Relevance
“…3, D and E). A similar conclusion was reported in which the 3Ј-CS1 involving the same nucleotides that constitute PK1 was mutated in the WNV replicon (43). Their results showed that specific bases in the 5Ј-and 3Ј-CS1 are important for replication, regardless of complementarity.…”
Section: Discussionsupporting
confidence: 65%
See 1 more Smart Citation
“…3, D and E). A similar conclusion was reported in which the 3Ј-CS1 involving the same nucleotides that constitute PK1 was mutated in the WNV replicon (43). Their results showed that specific bases in the 5Ј-and 3Ј-CS1 are important for replication, regardless of complementarity.…”
Section: Discussionsupporting
confidence: 65%
“…A long range RNA-RNA interaction between these complementary motifs resulting in circularization of the genome was postulated (40) and demonstrated by atomic force microscopy (13). The physical and functional RNA-RNA interaction between 5Ј-and 3Ј-CS1 was shown to be essential for RNA synthesis in vitro (10,41) and in replication of subgenomic replicons or infectious clones in cultured mammalian cells (11,12,14,42,43). In addition to the 5Ј-and 3Ј-CS1, two regions of complementarity in the 5Ј-and 3Ј-terminal sequences, termed the upstream of AUG region (UAR), were also identified as a requirement for cyclization and RNA replication (13,17,44).…”
mentioning
confidence: 99%
“…BHK(VEErep/C*-E/Pac) cells expressing the WNV C-prM/E proteins (8), BHK(VEErep/Pac-Ubi-C*) cells expressing the WNV C protein (52), and BHK(VEErep/Pac-Ubi-D2C) cells expressing the DENV2 C protein (see below) were propagated at 37°C in Dulbecco's MEM supplemented with 10% FBS and 10 g/ml puromycin as previously described (8). The WNV derived from an infectious cDNA engineered from a 2002 WNV isolate was previously described (49), and RepliVAX WN.2 has also been described (52). The DENV2 used for in vitro and animal studies consisted of a high-passage, mouse brainadapted derivative of the New Guinea C (NGC) strain.…”
Section: Methodsmentioning
confidence: 99%
“…To further demonstrate the functionality of the new replicon system, we tested a replicon with a mutation in the 5Ј CS that was previously shown to abrogate RNA replication (Fig. 1B [WNV-SPACER-EMCV-Rep CS m4/7-5Ј]) (15) and confirmed inhibition of replication.…”
mentioning
confidence: 99%